Live News Categoriesmarket

ACXP.O (ACXP.O) News

Track canonical SquawkNews coverage tagged to ACXP.O, ACXP.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ACXP.O Asset market Sector Markets 90 days 1 Updated Sep 29, 2026, 12:07 PM UTC Open live news feed

M Acurx enrolls first patient in PATHFINDER Phase 2 trial of ibezapolstat Acurx enrolled the first patient in PATHFINDER, a Phase 2 study of ibezapolstat in multiply recurrent C. difficile infection, with no results yet. The trial will assess clearing infection and reducing repeat episodes; ma EARNINGS | Sep 29, 2026, 12:07 PM UTC